Omega-3 health claim
This article was originally published in The Tan Sheet
Executive Summary
FDA amends, shortens qualified health claim for fatty acids/coronary heart disease. In Feb. 8 letter to Emord & Associates, agency says it will allow use of the claim: "Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the data and determined that, although there is scientific evidence supporting the claim, the evidence is not conclusive." Supplements bearing claim must not recommend intake exceeding 2 g/day EPA and DHA. Pearson plaintiffs had complained original 78-word claim, approved in October 2000, failed to accurately summarize scientific knowledge about fatty acids and was too lengthy (1"The Tan Sheet" Nov. 6, 2000, p. 3)...